Refametinib (R) loxacin Hydrochloride AY 77 exhibits bias for

AY 77 exhibits bias for Ca2+ over ERK1/2 signaling (EC50 values are 40 nM for Ca2+ release versus 2 μM for ERK1/2 phosphorylation)

5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1

24)25)19-16(21(28)29)11-18(32-19)20(26)27-15-6-8-33(30

Activation of the angiotensin-(1-7) receptor Mas

Refametinib (R) loxacin Hydrochloride AY 77 exhibits bias forRefametinib R enantiomer is a potent, selective and allosteric inhibitor of MEK1 2 in enzyme inhibition assays. Refametinib R has been reported to inhibit MEK activity and inhibit anchorage dependent growth. Moreover, it has shown a potent tumor growth inhibition (TGI) in the human A375 and colon carcinoma Colo205 tumor xenograft models. Product information CAS Number: 923032 38 6 Molecular Weight: 572. 34 Formula: C19H20F3IN2O5S Synonym: BAY 869766 R